RYTM – Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals, Inc.

RYTM

$112.16

Name : Rhythm Pharmaceuticals, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $7,776,154,624.00

EPSttm : -2.91

Rhythm Pharmaceuticals, Inc.

$112.16

1.57%

$1.79

RYTM — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

17.53

Margin Of Safety %

Put/Call OI Ratio

0.35

EPS Next Q Diff

-0.08

EPS Last/This Y

-1.83

EPS This/Next Y

3.64

Price

112.18

Target Price

140.12

Analyst Recom

1.2

Performance Q

-3.33

Upside

-190.8%

Beta

2.11

Ticker: RYTM

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-13	RYTM	86.65	0.49	0.00	3594
2026-10-14	RYTM	86.71	0.49	999.99	3586
2026-10-15	RYTM	87.84	0.49	0.00	3587
2026-10-16	RYTM	86.2	0.48	0.06	3625
2026-10-19	RYTM	88.26	0.56	0.00	3180
2026-10-20	RYTM	90.27	0.55	0.00	3203
2026-10-21	RYTM	88.71	0.55	0.00	3211
2026-10-22	RYTM	90.82	0.55	0.00	3218
2026-10-23	RYTM	89.17	0.55	0.22	3220
2026-10-26	RYTM	89.5	0.54	140.00	3230
2026-10-27	RYTM	92.14	0.54	13.20	3235
2026-10-28	RYTM	91.96	0.55	86.00	3243
2026-10-29	RYTM	93.05	0.56	6.48	3265
2026-10-30	RYTM	92.59	0.58	0.29	3322
2026-11-02	RYTM	93.54	0.51	0.08	3722
2026-11-03	RYTM	86.22	0.39	0.24	4701
2026-11-04	RYTM	115.61	0.39	0.05	5132
2026-11-05	RYTM	105.01	0.28	0.04	6907
2026-11-06	RYTM	112.19	0.36	0.15	6037
2026-11-09	RYTM	113.69	0.32	0.72	7463
2026-11-10	RYTM	113.86	0.35	0.05	7883
2026-11-11	RYTM	112.04	0.35	0.33	7945
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-13	RYTM	86.60	8.3	-	-3.07
2026-10-14	RYTM	86.70	8.6	-	-3.06
2026-10-15	RYTM	87.97	8.6	-	-3.06
2026-10-16	RYTM	86.19	8.6	-	-3.06
2026-10-19	RYTM	88.21	8.6	-	-3.06
2026-10-20	RYTM	88.21	8.6	-	-3.06
2026-10-21	RYTM	90.27	9.4	-	-3.04
2026-10-22	RYTM	90.91	9.4	-	-3.04
2026-10-23	RYTM	89.19	9.4	-	-3.04
2026-10-26	RYTM	89.61	9.4	-	-3.04
2026-10-27	RYTM	92.13	9.4	-	-3.04
2026-10-28	RYTM	92.00	9.4	-	-3.04
2026-10-29	RYTM	93.19	9.4	-	-3.04
2026-10-30	RYTM	92.53	9.4	-	-3.04
2026-11-02	RYTM	93.59	9.5	-	-3.04
2026-11-03	RYTM	86.26	9.5	-	-3.04
2026-11-04	RYTM	116.93	0.2	-	-3.04
2026-11-05	RYTM	105.17	0.2	-	-3.04
2026-11-06	RYTM	112.22	0.7	-	-3.05
2026-11-09	RYTM	113.69	0.7	-	-3.05
2026-11-10	RYTM	114.01	-100.0	-	-4.94
2026-11-11	RYTM	112.18	-100.0	-	-4.94
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-13	RYTM	-9.92	5.71	16.28
2026-10-14	RYTM	-9.92	5.71	16.28
2026-10-15	RYTM	-9.92	5.71	16.28
2026-10-16	RYTM	-9.92	5.71	16.28
2026-10-19	RYTM	-9.92	5.73	16.28
2026-10-20	RYTM	-9.92	5.73	16.28
2026-10-21	RYTM	-9.92	5.73	16.28
2026-10-22	RYTM	-9.92	5.73	16.28
2026-10-23	RYTM	-9.92	5.73	16.28
2026-10-26	RYTM	-9.92	5.59	16.28
2026-10-27	RYTM	-9.92	5.59	16.64
2026-10-28	RYTM	-9.92	5.59	16.64
2026-10-29	RYTM	-9.92	5.59	16.64
2026-10-30	RYTM	-9.92	5.59	16.64
2026-11-02	RYTM	-9.92	5.49	16.64
2026-11-03	RYTM	-9.92	5.49	16.64
2026-11-05	RYTM	-9.92	5.49	16.64
2026-11-06	RYTM	-9.85	5.49	16.64
2026-11-09	RYTM	-9.85	3.34	16.52
2026-11-10	RYTM	-9.85	3.34	16.52
2026-11-11	RYTM	-9.85	3.34	17.53
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

-0.61

Avg. EPS Est. Current Quarter

-3.2

Avg. EPS Est. Next Quarter

-0.69

Insider Transactions

-9.85

Institutional Transactions

3.34

Beta

2.11

Average Sales Estimate Current Quarter

108

Average Sales Estimate Next Quarter

112

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

8.2

Max Drawdown 5-Year %

-76.9

Target Price

140.12

P/E

Forward P/E

PEG

P/S

27.7

P/B

88.38

P/Free Cash Flow

EPS

-2.91

Average EPS Est. Cur. Y

-4.94

EPS Next Y. (Est.)

-1.3

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-70.63

Relative Volume

0.74

Return on Equity vs Sector %

-100

Return on Equity vs Industry %

-100

EPS 1 7Days Diff

-1.9

EPS 1 30Days Diff

-1.84

EBIT Estimation

◆ RYTM Healthcare

$112.16

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

14/20

Pullback

0/25

Volume

6/15

Valuation

7/20

TP/AR

3/10

Options

6/10

RSI

65.5

Range 1M

97.2%

🚀

Momentum Growth

Ride accelerating trends

WATCH

Momentum

18/25

Growth

19/30

Estimates

4/20

Inst/Vol

5/15

Options

9/10

EPS Yr

-54.4%

EPS NY

78.5%

52W%

83.3%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟡 HOLD +24.9% upside

Quality

6/30

Valuation

6/30

Growth

14/25

Stability

7/10

LT Trend

4/5

Upside

+24.9%

Quality

RYTM — P/E HistoricalBiotechnology

Rhythm Pharmaceuticals, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 414

Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases in the United States and internationally. The company's lead product candidate is IMCIVREE (setmelanotide), a rare melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1, leptin receptor (LEPR) deficiency obesity, Bardet-Biedl and Alström syndrome, Prader-Willi syndrome, and hypothalamic obesity. It is in Phase 3 clinical trials for treating acquired hypothalamic obesity, congenital hypothalamic obesity, pro-opiomelanocortin (POMC) and LEPR insufficiency obesities, SRC1 deficiency obesity, and SH2B1 deficiency obesity; and in phase 2 clinical trails for the treatment of Prader-Willi syndrome and MC4R deficiency. The company is also developing bivamelagon, an investigational oral small molecule MC4R agonist that is in phase 2 clinical trial for the treatment of MC4R pathway diseases; and RM-718, a next generation MC4R peptide agonist that is in phase 1 clinical trial for the treatment of hypothalamic obesity. The company was formerly known as Rhythm Metabolic, Inc. and changed its name to Rhythm Pharmaceuticals, Inc. in October 2015. Rhythm Pharmaceuticals, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

RYTM

Latest News

—

Caricamento notizie per RYTM…

stock quote shares RYTM – Rhythm Pharmaceuticals Inc. Stock Price stock today

news today RYTM – Rhythm Pharmaceuticals Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch RYTM – Rhythm Pharmaceuticals Inc. yahoo finance google finance

stock history RYTM – Rhythm Pharmaceuticals Inc. invest stock market

stock prices RYTM premarket after hours

ticker RYTM fair value insiders trading

RYTM – Rhythm Pharmaceuticals Inc.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: RYTM

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y